These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28294568)

  • 1. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.
    Fang J; Wu Z; Cai C; Wang Q; Tang Y; Cheng F
    J Chem Inf Model; 2017 Nov; 57(11):2657-2671. PubMed ID: 28956927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome modeling and phenotypic assays for cancer precision medicine.
    Jeong E; Moon SU; Song M; Yoon S
    Arch Pharm Res; 2017 Aug; 40(8):906-914. PubMed ID: 28766239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.
    Soysal E; Lee HJ; Zhang Y; Huang LC; Chen X; Wei Q; Zheng W; Chang JT; Cohen T; Sun J; Xu H
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):188-196. PubMed ID: 28296354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network medicine: finding the links to personalized therapy.
    Chen JY; Piquette-Miller M; Smith BP
    Clin Pharmacol Ther; 2013 Dec; 94(6):613-6. PubMed ID: 24241633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
    Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer as a paradigm for precision oncology in solid tumours.
    Schallenberg S; Merkelbach-Bruse S; Buettner R
    Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs.
    Zolotovskaia M; Sorokin M; Garazha A; Borisov N; Buzdin A
    Methods Mol Biol; 2020; 2063():207-234. PubMed ID: 31667773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecules, big impact: 20 years of targeted therapy in oncology.
    Bedard PL; Hyman DM; Davids MS; Siu LL
    Lancet; 2020 Mar; 395(10229):1078-1088. PubMed ID: 32222192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.